Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.3600
-0.0100 (-2.70%)
Aug 28, 2025, 3:59 PM EDT
Vaxart Market Cap
Vaxart has a market cap or net worth of $89.08 million as of August 29, 2025. Its market cap has decreased by -34.72% in one year.
Market Cap
89.08M
Enterprise Value
81.83M
Revenue
80.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.36
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 89.08M, an increase of 47.61%. That is a compound annual growth rate of 5.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 82.23M | -45.40% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | 625.07M | 3,636.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 838.96M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 654.83M |
| Elite Pharmaceuticals | 610.28M |
| CytoDyn | 401.32M |
| Northwest Biotherapeutics | 390.55M |
| American Oncology Network | 376.01M |